Clinical Breast Cancer

简称 CLIN BREAST CANCER ·UNITED STATES ·出版周期 Bimonthly ·年均收录 88 篇

2.5

最新影响因子

3.10%

自引率

较易

投稿难度

平均3月

审稿周期

期刊简介

Clinical Breast Cancer是一本专注于乳腺癌研究的国际学术期刊，ISSN号为1526-8209，由美国出版商Elsevier出版，出版地为美国，出版周期为双月刊。该期刊的影响因子根据最新数据约为3.0左右，属于非开放获取（非OA）期刊，并被SCI收录，在中科院分区中通常位于医学类3区或4区。杂志的发文特点集中于乳腺癌的临床与转化研究，涵盖诊断、治疗、预后及分子机制等领域，尤其关注创新疗法和临床试验成果。其质量在乳腺癌领域具有一定影响力，但影响因子相对中等，可能存在投稿竞争激烈或审稿周期较长的风险，适合从事乳腺癌研究的临床医生和科研人员投稿。

影响因子趋势

近期发表

Prognostic Paradox of Breast Invasive Micropapillary Carcinoma 2026-08-12

Intraoperative and Perioperative Outcomes of Breast-Conserving Surgery After Neoadjuvant Systemic Therapy: A Retrospective Cohort Study 2026-08-12

CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety 2026-07-31

Determination of Body Perceptions and Preferences for Breast Reconstruction in Mastectomy Patients 2026-07-21

Clinical Outcomes and Chemoprevention in High-Risk Breast Lesions: A Comparison of Atypical Ductal Hyperplasia and Lobular Carcinoma In Situ 2026-09-02

CTSG Suppresses Breast Cancer Progression by Inhibiting the EGFR/ERK Signaling Pathway and Enhancing CD8⁺ T Cell Activation 2026-07-26

From Surveillance to Intervention in Breast Cancer-Related Lymphedema: Clinical Thresholds, Longitudinal Monitoring, and Actionable Care Pathways 2026-09-02

Phenotypic Age Acceleration Predicts Survival Outcomes in HR+/HER2-Negative Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Real-World Cohort Study 2026-07-17

Cryoablation Within the Evolving Paradigm of Multidisciplinary Breast Cancer Treatment De-Escalation 2026-07-27

Predictors of Surgical Decision-Making After Neoadjuvant Chemotherapy for Breast Cancer 2026-07-17